Search Results
Aug 24, 2026, 19:12 ET FDA approves IMAAVY® (nipocalimab-aahu) as first-ever treatment for warm autoimmune hemolytic anemia (wAIHA), representing a landmark advancement for patients
reduce pathogenic immunoglobulin G (IgG) autoantibodies while also preserving B-cell functionWarm autoimmune hemolytic anemia is a rare, life-threatening disease in which autoantibodies cause the destruction of red blood cells, leading to severe anemia and debilitating fatigueThe
More news about: Johnson & Johnson
Aug 24, 2026, 16:32 ET Capricor Therapeutics, Inc. Investor Alert - Robbins LLP Reminds CAPR Investors with Significant Losses of the Opportunity to Lead the Class Action Lawsuit Against the Company
podcast. Why Was Capricor Therapeutics Sued?Capricor is a biotechnology company focused on developing cell and exosome-based therapeutics for rare diseases, including Duchenne muscular dystrophy ("DMD"). The Company's lead product candidate is Deramiocel, an investigational cell therapy intended
More news about: Robbins LLP
Aug 24, 2026, 15:57 ET New National Survey Identifies the Bitcoin Messages That Resonate With Everyday Americans
addressed directly, interest in Bitcoin rose," said Alli Shaw, Founder & President, Neighborhood Bitcoin. "That is rare in message testing, but shows that this messaging does exactly what it is intended to do: meet people where they are with answers to the concerns that
More news about: Bitcoin Policy Institute
Aug 24, 2026, 15:53 ET Foundations to Freedom Named Primary Partner of Carson Ware for the Winn-Dixie 250 at Daytona International Speedway
and recovery, and he is the son of Rick Ware, longtime owner of NASCAR Cup Series organization Rick Ware Racing. That combination gives him something rare: the ability to stand in a room full of people in recovery and speak from lived experience while also having a national platform to carry that message
More news about: Foundations to Freedom
Aug 24, 2026, 12:15 ET U.S. Air Force Selects LGNDX for Phase III Deployment of Defense Acquisition Platform
Rare transition from SBIR Phase I to Phase III validates LGNDX's platform designed to accelerate technology adoption across the defense ecosystem. WASHINGTON, D.C., Aug. 24, 2026 /PRNewswire/ -- LGNDX, a defense
More news about: LGNDX
Aug 24, 2026, 12:05 ET Three Cleveland Bakeries, One Online Auction: Colossal Cupcakes Liquidates Nearly 300 Lots
Freeze CS10-237 countertop at $8,500 retail, and a Sumstar S850AC 3-flavor floor model at $5,500 retail. Four in one auction is rare.Bakers Pride Cyclone GDCO11E Double-Stack Electric Convection Oven — $12,500 retail — plus a Southbend SLES/20SC double-stack
More news about: Auction Factory
Aug 24, 2026, 12:00 ET SELENA GOMEZ ANNOUNCES FOURTH ANNUAL RARE IMPACT FUND BENEFIT SUPPORTING YOUTH MENTAL HEALTH
here.ABOUT THE RARE IMPACT FUND The Rare Impact Fund was launched by Selena Gomez as part of her focus on addressing mental health. One percent of all Rare Beauty by Selena Gomez sales are donated to the Rare Impact Fund. The Rare Impact Fund raises additional funds
More news about: Rare Beauty
Aug 24, 2026, 11:42 ET St. Petersburg Vein Clinic Opens as United Vein & Vascular Centers Expands in Pinellas County, Florida
treatment."Every member of this team was welcoming, professional, and clearly excellent at what they do. It's rare to find a medical office where every single person contributes to such a positive experience. Words truly can't describe
More news about: United Vein & Vascular Centers
Aug 24, 2026, 11:00 ET BRC Therapeutics Appoints Biopharma Veteran Chandra Ramanathan as Executive Vice President of Commercialization and Strategy
BRC Therapeutics. "He has led launches at some of the most respected companies in our industry, built innovation engines from the ground up, and has a rare ability to move fluidly between science, innovation strategy, and commercial strategy. As we advance our pipeline in CRPS, AIIA, RLS and additional
More news about: BRC Therapeutics
Aug 24, 2026, 09:15 ET Newark Alliance Names Technology and Government Leader Solomon Steplight as New Chief Executive Officer
advance strategic initiatives, expanded broadband infrastructure and contributed to the development of the municipal budget."Solomon brings a rare combination of deep knowledge of Newark, proven executive leadership and a track record of bringing people and institutions together to get things done,"
More news about: Newark Alliance
Aug 24, 2026, 09:00 ET Phoenix Children's Names Jamie Wiggins Executive Vice President, Chief Operating Officer and Chief Nursing Executive
"Jamie brings a combination of expertise that is incredibly rare in healthcare," said John R. Nickens IV, President
More news about: Phoenix Children's
Aug 24, 2026, 08:37 ET World Media Gather at the Center for Islamic Civilization in Uzbekistan to Tell the Story of Islam's Legacy in a New Way
addition, the complex includes a research center, digitization laboratories, as well as conservation and restoration workshops. Visitors will be able to see rare artifacts of different historical periods, returned from abroad, including those purchased at international auctions and from private collectors at
More news about: Center for Islamic Civilization in Uzbekistan
Aug 24, 2026, 08:00 ET PTC Therapeutics Announces New Sephience™ (sepiapterin) Data Reinforcing Broad Patient Benefits Including Sustained Metabolic Control and Diet Liberalization as well as Consistent Favorable Safety Profile
Full Prescribing Information.About PhenylketonuriaPhenylketonuria (PKU) is a rare, inherited metabolic disease, characterized by the body's inability to break down an essential amino acid called phenylalanine (Phe) and which can result
More news about: PTC Therapeutics, Inc.
Aug 24, 2026, 07:05 ET REGENXBIO Announces Regulatory Update on RGX-121 for MPS II
with neuronopathic MPS II experience a multitude of neurodevelopmental and systemic effects. While imaging natural history is limited for this ultra-rare disease, I believe that asymptomatic, likely benign findings like these may be inherent to the impact of Hunter Syndrome throughout the body," said
More news about: REGENXBIO Inc.
Aug 24, 2026, 07:00 ET Vanda Pharmaceuticals Granted Orphan Designation for Imsidolimab for the Treatment of Generalized Pustular Psoriasis by the European Commission
following an opinion from EMA's COMP for medicines intended for the diagnosis, prevention, or treatment of life-threatening or chronically debilitating rare conditions. Among other criteria, the condition must affect fewer than 5 in 10,000 people in the EU. Benefits include protocol assistance, reduced regulatory
More news about: Vanda Pharmaceuticals Inc.
Aug 24, 2026, 07:00 ET Nouvelle étude mondiale d'IKEA : Près de 4 personnes sur 10 mènent une « protestation silencieuse » contre le désordre qui règne chez elles
La vie à la maison devient de plus en plus trépidante et l'espace se fait de plus en plus rare. C'est pourquoi, cette année, IKEA s'attache à aider ses clients à retrouver la sérénité, et pas seulement à optimiser le rangement.Ce rapport,
More news about: IKEA
Aug 24, 2026, 07:00 ET BRINSUPRI® (brensocatib) Approved by Japan's Ministry of Health, Labour and Welfare for the Treatment of Patients With Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease
commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology & Inflammation, and Neuro & Other Rare. The Company's research engine is advancing a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, RNA end-joining,
More news about: Insmed Incorporated
Aug 24, 2026, 05:35 ET European Commission grants orphan designation for Lundbeck's investigational anti-ACTH monoclonal antibody asedebart for Cushing's syndrome of endogenous origin
treatment for rare conditions characterized by excess ACTH, with proof-of-concept trials ongoing in CD and classic congenital adrenal hyperplasia (CAH) to evaluate efficacy and safety.⁵-⁷With this designation, asedebart continues to build regulatory momentum across rare ACTH-driven disorders.
More news about: H. Lundbeck A/S
Aug 24, 2026, 05:33 ET European Commission grants orphan designation for Lundbeck's investigational anti-ACTH monoclonal antibody asedebart for Cushing's syndrome of endogenous origin
treatment for rare conditions characterized by excess ACTH, with proof-of-concept trials ongoing in CD and classic congenital adrenal hyperplasia (CAH) to evaluate efficacy and safety.⁵-⁷With this designation, asedebart continues to build regulatory momentum across rare ACTH-driven disorders.
More news about: H. Lundbeck A/S
Aug 24, 2026, 03:01 ET ImmunoForge Selected for the Ministry of SMEs and Startups' 'Global TIPS R&D' Program… "Expansion of the LMT Platform"
2026 /PRNewswire/ -- ImmunoForge (Co-CEOs Sung-Min Ahn and Ki-Ho Chang), a biotech venture specializing in the development of therapeutics for rare diseases, announced that it has been finally selected for the 2026 Investment and Financing-Linked Technology Development Program (Global TIPS R&D),
More news about: ImmunoForge Co., Ltd.
Aug 24, 2026, 01:21 ET GC Biopharma's Hunter Syndrome Treatment 'Hunterase' Receives Drug Approval in India and Taiwan
- Secures approval for 'Hunterase IV' in India and both 'Hunterase IV & ICV' in Taiwan, accelerating expansion into the Asian rare disease market YONGIN, South Korea, Aug. 24, 2026 /PRNewswire/
More news about: GC Biopharma
Aug 21, 2026, 16:23 ET Lennar Announces Grand Opening of Prentis Branch in Scenic and Historic Rome, Georgia
"Prentis Branch gives homebuyers the rare combination of new construction close to the shopping, and dining in downtown Rome, highly regarded schools and some of Northwest Georgia's best outdoor
More news about: Lennar Corporation
Aug 21, 2026, 15:00 ET Tickets Now on Sale for The Moonwalkers: A Journey with Tom Hanks at South Florida PBS
Narrated by Tom Hanks, The Moonwalkers: A Journey with Tom Hanks combines breathtaking 360° projections, rare and remastered NASA footage, immersive spatial audio and powerful storytelling to transport visitors from the pioneering Apollo missions to the next
More news about: South Florida PBS
Aug 21, 2026, 12:24 ET Zhang Ziyi: the new face of Clarins Precious
globally recognized icon of cinema whose singular talent has earned world-wide acclaim. As part of her new role, she will champion authentic beauty, rare innovation and the exceptional craftmanship of Clarins Precious, our premium skin care line built on decades of scientific expertise, meticulous formulation
More news about: Clarins
Aug 21, 2026, 12:00 ET Sazerac Company Continues Investing in Kentucky with Acquisition of Garrard County Distilling
around the world.Over 550 of the world's most extraordinary brands are part of the Sazerac portfolio, including Buffalo Trace Bourbon, Eagle Rare, Weller, The Last Drop Distillers, Fireball Cinnamon Whisky, Southern Comfort, Wheatley Vodka, Myers's Rum, White X Cognac, Sazerac de Forge Cognac,
More news about: Sazerac